BofA Securities Adjusts Dentsply Sirona Price Target to $14
BofA Securities lowered its price target for Dentsply Sirona from $17 to $14 following the company's third-quarter earnings report.
Stocks · News reference
JP Morgan maintained its 'Neutral' rating on Dentsply Sirona while lowering the price target from $12.00 to $10.00 per share.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
BofA Securities lowered its price target for Dentsply Sirona from $17 to $14 following the company's third-quarter earnings report.
Dentsply Sirona announced its Q3 2026 financial results, reporting $836 million in net sales and an adjusted EPS of $0.29, while updating its full-year 2026 outlook.
The ANZ dental implants market is valued at USD 266.0 million in 2025 and is projected to reach USD 393.0 million by 2033, growing at a 5.0% CAGR. Growth is driven by aging populations, increased demand for prosthetics, and technological advances in implant materials. However, high treatment costs remain a significant barrier to market expansion, with 28% of Australians delaying dental care due to affordability concerns.
Dentsply Sirona is promoting the capabilities of its X-Smart Pro+ endodontic motor, emphasizing its integrated apex locator and advanced control technology.
Barrington Research has maintained its 'Outperform' rating on Dentsply Sirona while lowering its price target from $15 to $13.